Selzentry news from FiercePharma
News
Pfizer goes public with R&D pipeline
It's tough to take over the world when everyone can see your battle plans--or so thought Pfizer before CEO Jeffrey Kindler pledged transparency. Now the company's future can be viewed at its Read more...
Get more Selzentry coverage at:
Paid Research Reports
- Drug Repositioning Strategies - Serendipity by design
- eHealthInsight Series: Online Patient Recruitment Strategies - Optimizing the clinical trial process
- Pricing & Reimbursement - Seven Major Markets Update
- Innovative Clinical Trial Design and Management: Trends, success stories and impact upon R&D budgets
- The Emerging Role of Postmarketing Clinical Research: Regulatory issues, strategic drivers and overall trends